Kawasaki Disease symptoms, causes, and treatment options explained with expert pediatric care and early diagnosis at Liv Hospital.
Send us all your questions or requests, and our expert team will assist you.
Kawasaki Disease: Overview and Definition
What Is Kawasaki Disease?
Kawasaki Disease (also known as mucocutaneous lymph node syndrome) is an acute, febrile illness characterized by generalized inflammation of the blood vessels (vasculitis) throughout the body. It primarily affects children under the age of 5 and is the leading cause of acquired heart disease in children in developed nations.
While the inflammation can affect many organs, its most significant impact is on the coronary arteries, which supply blood to the heart muscle.
The exact cause of Kawasaki Disease remains unknown. However, researchers believe it is not contagious but rather an abnormal immune response triggered by an environmental factor (such as a virus or bacteria) in children who have a genetic predisposition.
Although the symptoms can be alarming, most children recover fully without permanent damage if the condition is identified and treated within the first 10 days of fever onset.
The Mechanism of Vasculitis
Kawasaki Disease causes the body’s immune system to attack the walls of the blood vessels. This inflammation can weaken the vascular walls, leading to the formation of coronary artery aneurysms (bulges in the blood vessels of the heart). If left untreated, these aneurysms can lead to blood clots, heart attacks, or internal bleeding.
Early medical intervention is designed specifically to “cool down” this inflammation before the heart is affected.
Symptoms and Conditions
What Are the Symptoms of Kawasaki Disease?
Diagnosis is largely clinical, meaning it is based on a collection of specific physical signs.
The primary symptom is a high fever lasting at least five days that does not respond to usual medications.
This is accompanied by “strawberry tongue,” red eyes, a generalized rash, and swollen lymph nodes.
Diagnosis and Evaluation
Diagnostic Tests for Kawasaki Disease
Because there is no single “Kawasaki Test,” doctors use a combination of laboratory blood work and cardiac imaging.
Evaluation focuses on monitoring inflammatory markers in the blood and using an Echocardiogram (ultrasound of the heart) to look for changes in the coronary arteries.
Treatment and Care
How Is Kawasaki Disease Treated?
The standard of care for Kawasaki Disease is highly effective and involves a two-pronged approach: Intravenous Immunoglobulin (IVIG) to calm the immune system and high-dose Aspirin to reduce inflammation and prevent blood clots. This treatment is most effective when started within the first 10 days of the fever.
Growth and Prevention
Preventing Long-Term Cardiac Complications
“Prevention” in Kawasaki Disease refers to preventing long-term cardiac complications. Most children return to their normal growth and activity levels quickly. However, those who develop coronary issues require lifelong follow-up with a pediatric cardiologist.
Epidemiology: Who is at Risk?
Kawasaki Disease is most prevalent in children of Asian descent, particularly Japanese and Korean, though it affects children of all ethnicities worldwide. It is slightly more common in boys than girls and occurs most frequently in the late winter and spring months.
The Three Phases of Illness
The disease typically progresses through three stages:
Incomplete (Atypical) Kawasaki Disease
Some children, particularly infants under 1 year old, may not show all five classic symptoms.
This is known as “Incomplete Kawasaki.” It is often harder to diagnose but carries a higher risk of heart complications because treatment might be delayed.
The Importance of Early Referral
Because the window for effective treatment is narrow, any child with an unexplained high fever for 4-5 days accompanied by redness in the eyes or mouth should be evaluated by a pediatric specialist immediately.
A Multidisciplinary Approach
At Liv Hospital, we manage Kawasaki Disease through a collaborative “Heart-Immune Board.” This team includes pediatric cardiologists, infectious disease specialists, and immunologists to ensure that inflammation is quenched rapidly and the coronary arteries are protected.
How Does Liv Hospital Treat Kawasaki Disease?
At Liv Hospital, Kawasaki Disease is managed as a time-critical emergency. Our Pediatric Cardiology team uses advanced 3D echocardiography to detect even small changes in coronary arteries and follows international gold-standard protocols for IVIG treatment within the critical 10-day window.
With a multidisciplinary approach, we focus on rapid recovery and long-term heart protection to support every child’s healthy future.
Send us all your questions or requests, and our expert team will assist you.
No. Kawasaki Disease cannot be passed from person to person like a cold or flu.
Most children treated early (about 75–80%) recover fully and develop no coronary artery complications.
Although usually avoided, Aspirin helps reduce inflammation and prevent clotting in Kawasaki Disease when used under strict medical supervision.
Recurrence is very rare and occurs in less than 2% of children.
IVIG is generally safe but may temporarily reduce the effectiveness of live vaccines for several months.
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 71 24
